What Is Spinal Cord Stimulation?
Spinal cord stimulation (SCS) is an advanced, reversible neuromodulation therapy that delivers carefully calibrated electrical impulses to the dorsal columns of the spinal cord to modify pain signal processing before signals reach the brain. It is one of the most effective treatments available for complex chronic pain conditions — particularly those that have not responded adequately to medications, physical therapy, injections, or prior surgery. SCS is FDA-approved for multiple chronic pain indications and is supported by decades of high-quality clinical evidence showing 50–70% pain reduction in properly selected patients.
Unlike treatments that target a single anatomic pain generator, SCS works at the neural level — altering how pain signals are processed throughout the central nervous system. Modern SCS systems have evolved dramatically, with high-frequency (10 kHz), burst, and closed-loop stimulation waveforms that achieve pain relief without the paresthesia (tingling sensation) associated with older conventional systems. These advances have significantly improved patient acceptance and outcomes.
Conditions Treated with SCS
- Failed back surgery syndrome (FBSS) — persistent or recurrent back and leg pain following spinal surgery; one of the strongest evidence bases for SCS, with multiple RCTs showing superiority over repeat surgery and medical management
- Complex regional pain syndrome (CRPS) Type I and II — severe neuropathic pain condition with burning, skin changes, and autonomic dysfunction; SCS is the most evidence-based treatment for refractory CRPS
- Refractory diabetic peripheral neuropathy — FDA-approved indication; SCS provides significant relief for painful neuropathy that has failed medical management
- Chronic intractable low back and leg pain — for carefully selected patients with radicular or central sensitization pain patterns not responsive to other interventions
- Post-laminectomy syndrome — ongoing neuropathic pain following laminectomy or discectomy
- Peripheral neuropathy from various causes — trauma, post-surgical, and idiopathic neuropathy causing significant functional impairment
How SCS Works
The traditional gate control theory — where large-diameter fibers activated by stimulation inhibit pain-transmitting small-fiber input — has been expanded significantly by modern research. High-frequency and burst SCS systems achieve pain relief through additional mechanisms including activation of GABA-ergic inhibitory interneurons, modulation of descending pain inhibitory pathways, and reduction of central sensitization by normalizing hyperexcitable neural circuits in the dorsal horn.
The clinical implication is significant: paresthesia-free stimulation at frequencies above 1,000 Hz (high-frequency SCS, commercially known as Nevro HF10) and burst stimulation produce pain relief without the constant tingling sensation of conventional SCS. Patients describe the experience as simply "the pain is gone" rather than tingling masking the pain sensation.
The SCS Process: From Evaluation to Implantation
Patient Selection and Evaluation
Careful patient selection is the most important determinant of SCS outcomes. Standard criteria include: chronic pain of at least 6 months duration, failure of conservative treatments (medications, physical therapy, appropriate injections), no untreated psychological conditions that would impair outcomes, no active infection or uncorrected bleeding disorder, and pain with a known neuropathic mechanism. A psychological evaluation is a standard part of the assessment to identify factors that predict outcome.
The Trial Period
Before permanent implantation, every SCS candidate undergoes a trial period — typically 5–7 days — with temporary leads placed through a needle procedure under fluoroscopic guidance (no incision required). The leads are connected to an external trial generator worn on a belt. If the trial achieves 50% or greater reduction in pain with improved function, the system is implanted permanently. The trial success rate in carefully selected patients is approximately 75–80%.
Permanent Implantation
Permanent implantation is an outpatient surgical procedure performed under light sedation and local anesthesia. Permanent leads are placed epidurally and anchored, and the implantable pulse generator (IPG) is placed subcutaneously in the flank, buttock, or abdomen. The entire procedure takes 1–2 hours. Recovery involves activity restrictions for 6–8 weeks while lead anchoring and tissue healing occur. Modern rechargeable IPGs last 8–10+ years before requiring replacement.
Benefits of Modern SCS
- 50–70% pain reduction in appropriately selected patients
- Significant reduction in opioid medication use
- Improved functional status and quality of life
- Completely reversible — the system can be removed at any time
- Rechargeable batteries with 8–10 year longevity
- MRI-compatible systems now available
- Paresthesia-free stimulation with modern waveforms
- Remote monitoring and programming adjustments via smartphone app